Company Overview

Cronos Australia is committed to providing Australian patients access to the highest quality medicinal cannabis products, as well as supplying export markets globally. Our vision is to become a leading health and wellness company in the Asia Pacific region with a portfolio of cannabinoid products – including THC and CBD.

Cronos Australia has secured all the necessary Australian licences to operate – including import and export licences. Our business model is underpinned by development of innovative product and brands development, outsourced manufacturing and distribution for Australia and target export markets.

Cronos Australia was established as a 50/50 joint venture between a global cannabinoid company, Cronos Group Inc (dual listed - NASDAQ:CRON, TSX:CRON) and NewSouthern Capital, a Melbourne-based private equity firm.

The relationship with Cronos Group Inc, provides via sole, territorial licences, intellectual property and trademarks, know-how, plant genetics, in-market brands, and potential access to markets that forms part of Cronos Australia’s growth plans.


We are aware of certain scams in which parties claim to be buying shares in Cronos Australia Limited or Cronos Group Inc. on behalf of investors.

If you have been cold-called by a party you do not know regarding the purchase of shares, we recommend you contact us first. You can contact us on 0418 351 127 or via email at